Clinical Trial Update: Treatment Effect of Saxagliptin Compared With Placebo in Patients With Type 2 Diabetes and Renal Impairment [Phase 3]

View source ↗

Summary

This Clinical Trial Update reports a Phase 3 study comparing Saxagliptin to placebo in patients with Type 2 diabetes mellitus and renal impairment, with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Onglyza (Saxagliptin)

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes | Phase 3 | Status: COMPLETED | Results posted: 2010-07-07